Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics reported after the market closed on Thursday that its first quarter revenues rose 125 percent year over year, driven primarily by an increase in the sale of consumable test kits.

For the three months ended March 31, 2019, the company's revenues were $1.8 million, compared to $801,000 in Q1 2018. It missed the analysts' average estimate of $2.1 million.

In the quarter, the company reported it added 75 commercially contracted instruments, compared to 11 in the first quarter of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.